New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2013
07:45 EDTACORAcorda Therapeutics downgraded to Neutral from Buy at MKM Partners
MKM Partners downgraded Acorda due to valuation. Price target is $31.
News For ACOR From The Last 14 Days
Check below for free stories on ACOR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 17, 2014
11:07 EDTACORAcorda sues Mylan over plans to duplicate Ampyra MS drug, Bloomberg says
July 9, 2014
06:45 EDTACORAcorda Therapeutics to initiate Phase 3 clinical trial for dalfampridine
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use